SCHEMBL175216

SCHEMBL175216

NC(=O)CCc1nccs1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.43
ALDH1A1 P00352 3/20 0.38
TSHR P16473 2/20 0.37
NOS1 P29475 1/20 0.37
HSD17B10 Q99714 1/20 0.37
COPS5 Q92905 2/20 0.36
PLA2G4A P47712 1/20 0.36
CYP2C19 P33261 1/20 0.36
PKM P14618 1/20 0.36
CES1 P23141 1/20 0.36
PSMD14 O00487 2/20 0.35
SLC6A3 Q01959 1/20 0.35
TRPM8 Q7Z2W7 1/20 0.35
STAMBP O95630 1/20 0.34
CAPN1 P07384 1/20 0.34
CYP3A4 P08684 1/20 0.34
NAMPT P43490 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL31146299 0.98 FDPS (0.42) FDPSALDH1A1TSHRNOS1HSD17B10
SCHEMBL2657137 0.89 PLA2G4A (0.44) FDPSALDH1A1TSHRNOS1HSD17B10
SCHEMBL2656867 0.87 CES1 (0.46) FDPSALDH1A1TSHRHSD17B10COPS5
SCHEMBL28011812 0.84 FDPS (0.46) FDPSALDH1A1TSHRCOPS5PLA2G4A
SCHEMBL992041 0.82 FDPS (0.44) FDPSALDH1A1TSHRHSD17B10COPS5
SCHEMBL4574427 0.81 ALDH1A1 (0.47) FDPSALDH1A1TSHRCOPS5PLA2G4A
SCHEMBL14257698 0.81 FDPS (0.43) FDPSALDH1A1TSHRCOPS5PLA2G4A
SCHEMBL474771 0.80
Hydrochloric Acid SCHEMBL6240582 0.78 FDPS (0.44) FDPSALDH1A1TSHRNOS1HSD17B10
Hydrochloric Acid SCHEMBL6237915 0.78 FDPS (0.44) FDPSALDH1A1TSHRNOS1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021116260-A1 QUINAZOLINE DERIVATIVES AS LPA RECEPTOR 2 INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2021-06-17 WO claimed
EP-2091947-A2 GLUCOKINASE ACTIVATORS Takeda San Diego, Inc. (US) 2009-08-26 EP claimed
EP-2049507-A2 MODULATORS OF GLUCOCORTICOID RECEPTOR, AND/OR AP-1, AND/OR NF-KB ACTIVITY AND USE THEREOF Brystol-Myers Squibb Company (US) 2009-04-22 EP claimed
EP-2049518-A2 INDAZOLE AND ISOINDOLE DERIVATIVES AS GLUCOKINASE ACTIVATING AGENTS. Takeda San Diego, Inc. (US) 2009-04-22 EP claimed
EP-2024329-A2 (2R)-2-[(4-SULFONYL)AMINOPHENYL]PROPANAMIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DOMPE' pha.r.ma s.p.a. (IT) 2009-02-18 EP claimed
EP-2001875-A2 GLUCOKINASE ACTIVATORS Takeda San Diego, Inc. (US) 2008-12-17 EP claimed
WO-2008116107-A2 PIPERAZINE DERIVATIVES AS GLUCOKINASE ACTIVATORS TAKEDA SAN DIEGO, INC. (US) 2008-09-25 WO claimed
WO-2008079787-A2 GLUCOKINASE ACTIVATORS TAKEDA SAN DIEGO, INC. (US) 2008-07-03 WO claimed
WO-2008021926-A2 MODULATORS OF GLUCOCORTICOID RECEPTOR, AND/OR AP-1, AND/OR NF-KB ACTIVITY AND USE THEREOF BRISTOL-MYERS SQUIBB COMPANY (US) 2008-02-21 WO claimed
WO-2007143434-A2 INDAZOLE AND ISOINDOLE DERIVATIVES AS GLUCOKINASE ACTIVATING AGENTS TAKEDA SAN DIEGO, INC. (US) 2007-12-13 WO claimed
WO-2007135080-A2 (2R)-2-[(4-SULFONYL)AMINOPHENYL]PROPANAMIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DOMPE' PHA.R.MA. S.P.A. (IT) 2007-11-29 WO claimed
WO-2007104034-A2 GLUCOKINASE ACTIVATORS TAKEDA SAN DIEGO, INC. (US) 2007-09-13 WO claimed
CN-1780821-A Heterocyclic kinase inhibitors. ABBOTT LAB (US) 2006-05-31 CN claimed
EP-1204649-A1 ARYLMETHYL-CARBONYLAMINO-THIAZOLE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS Pharmacia Italia S.p.A. (IT) 2002-05-15 EP claimed
WO-2001014353-A1 ARYLMETHYL-CARBONYLAMINO-THIAZOLE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA ITALIA, S.P.A. (IT) 2001-03-01 WO claimed
WO-2024126777-A1 HETEROAROMATIC COMPOUNDS ASTRAZENECA AB (SE) 2024-06-20 WO disclosed
US-RE49594-E1 Apelin receptor (APJ) agonists and uses thereof RESEARCH TRIANGLE INSTITUTE (US) 2023-08-01 US disclosed
WO-2004067521-A1 THIAZOLE DERIVATIVES AND THEIR USE AS VAP-1 INHIBITORS ASTELLAS PHARMA INC. (JP) 2004-08-12 WO disclosed
EP-1417189-A1 ACYLAMINOTHIAZOLE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE Sanofi-Aventis (FR) 2004-05-12 EP disclosed
WO-2003014095-A1 ACYLAMINOTHIAZOLE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE SANOFI-SYNTHELABO (FR) 2003-02-20 WO disclosed